Prise en charge des tumeurs ovariennes à la limite de la malignité

Sophie Camatte; Philippe Morice; Anne Thoury; Roman Rouzier; Patricia Pautier; Catherine Lhommé; Christophe Pomel; Pierre Duvillard; Damienne Castaigne

Prise en charge des tumeurs ovariennes à la limite de la malignité

Sophie Camatte, Philippe Morice, Anne Thoury, Roman Rouzier, Patricia Pautier, Catherine Lhommé, Christophe Pomel, Pierre Duvillard, Damienne Castaigne

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

Résumé

Low malignant potential ovarian tumor (LMPOT) represent 10% to 20% of epithelial ovarian tumors. Most important factors are: stage of disease, type of peritoneal implants (in patients with stage > I) and the presence of residual disease after surgery. Prognosis of patients with stage I LMPOT and/or patients with non invasive implants is excellent. Presence of a nodal involvement does not seem to affect the survival. Treatment is based on surgery with conservative one in young patients desiring a fertility preserving surgery. Adjuvant chemotherapy should be delivered only in (rare) cases of patients with invasive peritoneal implants.

Titre traduit de la contribution	Management of low-malignant borderline ovarian tumors
langue originale	Français
Pages (de - à)	491-497
Nombre de pages	7
journal	Reproduction Humaine et Hormones
Volume	16
Numéro de publication	7-8
état	Publié - 1 oct. 2003

mots-clés

Conservative treatment
Low malignant potential ovarian tumor
Peritoneal implants
Prognostic factors

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{886ef5aa807247d181f34f71a384f44d,

title = "Prise en charge des tumeurs ovariennes {\`a} la limite de la malignit{\'e}",

abstract = "Low malignant potential ovarian tumor (LMPOT) represent 10% to 20% of epithelial ovarian tumors. Most important factors are: stage of disease, type of peritoneal implants (in patients with stage > I) and the presence of residual disease after surgery. Prognosis of patients with stage I LMPOT and/or patients with non invasive implants is excellent. Presence of a nodal involvement does not seem to affect the survival. Treatment is based on surgery with conservative one in young patients desiring a fertility preserving surgery. Adjuvant chemotherapy should be delivered only in (rare) cases of patients with invasive peritoneal implants.",

keywords = "Conservative treatment, Low malignant potential ovarian tumor, Peritoneal implants, Prognostic factors",

author = "Sophie Camatte and Philippe Morice and Anne Thoury and Roman Rouzier and Patricia Pautier and Catherine Lhomm{\'e} and Christophe Pomel and Pierre Duvillard and Damienne Castaigne",

year = "2003",

month = oct,

day = "1",

language = "Fran{\c c}ais",

volume = "16",

pages = "491--497",

journal = "Reproduction Humaine et Hormones",

issn = "0994-3919",

number = "7-8",

}

TY - JOUR

T1 - Prise en charge des tumeurs ovariennes à la limite de la malignité

AU - Camatte, Sophie

AU - Morice, Philippe

AU - Thoury, Anne

AU - Rouzier, Roman

AU - Pautier, Patricia

AU - Lhommé, Catherine

AU - Pomel, Christophe

AU - Duvillard, Pierre

AU - Castaigne, Damienne

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Low malignant potential ovarian tumor (LMPOT) represent 10% to 20% of epithelial ovarian tumors. Most important factors are: stage of disease, type of peritoneal implants (in patients with stage > I) and the presence of residual disease after surgery. Prognosis of patients with stage I LMPOT and/or patients with non invasive implants is excellent. Presence of a nodal involvement does not seem to affect the survival. Treatment is based on surgery with conservative one in young patients desiring a fertility preserving surgery. Adjuvant chemotherapy should be delivered only in (rare) cases of patients with invasive peritoneal implants.

AB - Low malignant potential ovarian tumor (LMPOT) represent 10% to 20% of epithelial ovarian tumors. Most important factors are: stage of disease, type of peritoneal implants (in patients with stage > I) and the presence of residual disease after surgery. Prognosis of patients with stage I LMPOT and/or patients with non invasive implants is excellent. Presence of a nodal involvement does not seem to affect the survival. Treatment is based on surgery with conservative one in young patients desiring a fertility preserving surgery. Adjuvant chemotherapy should be delivered only in (rare) cases of patients with invasive peritoneal implants.

KW - Conservative treatment

KW - Low malignant potential ovarian tumor

KW - Peritoneal implants

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=1342279370&partnerID=8YFLogxK

M3 - Article 'review'

AN - SCOPUS:1342279370

SN - 0994-3919

VL - 16

SP - 491

EP - 497

JO - Reproduction Humaine et Hormones

JF - Reproduction Humaine et Hormones

IS - 7-8

ER -